Schiavi & Co’s Globus Medical GMED Stock Holding History

Schiavi & Co’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,500	Closed	-$207K	–	41
2024 Q4	$207K	Buy	+2,500	New	+$197K	0.08%	37
2024 Q3	–	Sell	-3,000	Closed	-$205K	–	34
2024 Q2	$205K	Buy	+3,000	New	+$179K	0.08%	31

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Schiavi & Co's GMED Position: Q1 2025 in Review

Schiavi & Co sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 2,500 shares — an estimated $207K sold.

Schiavi & Co first reported a position in GMED in Q2 2024 and held it in 2 quarters. The position peaked at $207K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

Schiavi & Co reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
Schiavi & Co sold 2,500 Globus Medical shares in Q1 2025, an estimated $207K.
Schiavi & Co first reported a position in Globus Medical in Q2 2024 and held it in 2 quarters.
Schiavi & Co's Globus Medical position peaked at $207K in Q4 2024.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Schiavi & Co's 13F filing for Q1 2025, filed 8 May 2025.